| Name | Title | Contact Details |
|---|---|---|
Michelle McGovern |
General Counsel | Profile |
Kerry Hunt Foster |
Assistant General Counsel | Profile |
Brett Silton |
Assistant General Counsel | Profile |
Marc Berger |
General Counsel | Profile |
Jeffrey Burd |
Vice President Legal | Profile |
Like everything from Combe, this family of Brimms products is famous for quality. These products reflect the exceptionally high standards Combe holds to provide customers with complete satisfaction.
MECA - Medical Equipment Compliance Associates is a Franklin, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
American Specialty Health Incorporated (ASH) provides health plans, employer groups, insurance carriers and trust funds with a wide range of wellness and population health, fitness and exercise, and specialty health care management programs to improve the health of their employees or members. Our Healthyroads® program is one of the largest employee wellness and prevention programs, serving hundreds of employer groups and more than 5 million members across the country. From telephone and online health coaching to wellness incentive programs to worksite health challenges, we offer it all under one roof. Our fitness and exercise services, including Silver&Fit® for Medicare Advantage members and Active&Fit® for commercial members, provide no-cost, low-cost, discount, or reimbursement fitness club/exercise center membership programs; walking, home exercise, and reward programs; as well as Internet-based exercise tools. And our specialty health provider programs for health plans contract with more than 30,000 specialty health care practitioners. Headquartered in Carmel, IN, with offices in San Diego, CA, Dallas, TX and Columbia, S.C., ASH has more than 1,200 employees and administers programs for more than 31 million members nationwide. Other products offered through ASH and its subsidiaries include ExerciseRewards™, FitnessCoach™, and others.
Neurotrope was formed in October 2012 to develop and market two product platforms, including a non-invasive diagnostic test for Alzheimer's Disease and a drug candidate called bryostatin for the treatment of Alzheimer's Disease, both of which are in the clinical testing stage. Neurotrope was formed for the primary purpose of commercializing certain technologies that were initially developed by Blanchette Rockefeller Neurosciences Institute ("BRNI") and its affiliates, for therapeutic or diagnostic applications for Alzheimer's Disease or other cognitive dysfunctions. These technologies have been under development since 1999 and have been financed through significant funding from a variety of non-investor sources. The Company expects that its first product, the diagnostic test for Alzheimer's Disease, will finish the testing phase of its development in 2015, whereupon the Company will evaluate the feasibility of its commercialization. In addition to bryostatin and the diagnostic test for Alzheimer's Disease, the Company intends to pursue development of two other technology platforms developed by and licensed from BRNI: the first, a platform for transporting drugs into the brain through the "blood-brain-barrier," and the second, a group of drugs for enhancing cognition, mood and alertness for neuropsychiatric conditions.
BC Mental Health & Addiction Services is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.